More importantly, however, when considering a biomarker panel consisting of all three miRNAs in combination with EphA2, that biomarker panel could diagnose early-stage PC (UICC I + II), late-stage PC (UICC III + IV), and HCs with 100% accuracy [150]. Here, EPHA2 is linked to pachyonychia congenita.